H-SIINFEK^L-OH

Rif. 3D-PP48021

Informazioni sul prodotto

• Nome: H-SIINFEK^L-OH

Descrizione

Peptide H-SIINFEK^L-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SIINFEK^L-OH include the following: A supramolecular vaccine platform based on alpha-helical peptide nanofibers Y Wu , PK Norberg, EA Reap , KL Congdon - ACS biomaterials , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsbiomaterials.7b00561 Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8+ T cell responses Y Si, Y Wen, SH Kelly , AS Chong , JH Collier - Journal of controlled release, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365918302165 Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters X Lu, JS Gibbs, HD Hickman , A David - Proceedings of the , 2012 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1208696109 Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific T Fifis, P Mottram, V Bogdanoska, J Hanley - Vaccine, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X0400427X A modular antigen presenting peptide/oligonucleotide nanostructure platform for inducing potent immune response S Tohumeken , N Gunduz , MB Demircan - Advanced , 2017 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adbi.201700015 Well-Defined Mannosylated Polymer for Peptide Vaccine Delivery with Enhanced Antitumor Immunity S Lv , K Song , A Yen , DJ Peeler - Advanced , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202101651 Cutting edge: N-hydroxy peptides: a new class of TCR antagonists S Hin, C Zabel, A Bianco , G Jung - The Journal of , 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/163/5/2363/32894 Tapasin edits peptides on MHC class I molecules by accelerating peptide exchange PVK Praveen, R Yaneva, H Kalbacher - European journal of , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200939342 Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and PJ Chefalo, CV Harding - The Journal of Immunology, 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/167/3/1274/35053 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide P Cascio, C Hilton , AF Kisselev, KL Rock - The EMBO , 2001 - embopress.orghttps://www.embopress.org/doi/full/10.1093/emboj/20.10.2357 Exact prediction of a natural T cell epitope O Rötzschke , K Falk, S Stevanovic - European journal of , 1991 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830211136 Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes NAW Lemmermann , K Gergely, V Böhm - Journal of , 2010 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02087-09 Formation and kinetics of MHC class I-ovalbumin peptide complexes on immature and mature murine dendritic cells NA Kukutsch, S Rossner, JM Austyn, G Schuler - Journal of investigative , 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022202X15409935 Improvement of the enzymatic stability of a cytotoxic T-lymphocyte-epitope model peptide for its oral administration MK Marschutz, W Zauner, F Mattner, A Otava - Peptides, 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978102001481 Ovalbumin epitope SIINFEKL self-assembles into a supramolecular hydrogel M Kamalov , H Kahlig, C Rentenberger, ARM Mullner - Scientific Reports, 2019 - nature.comhttps://www.nature.com/articles/s41598-019-39148-8 Tapasin enhances MHC class I peptide presentation according to peptide half-life M Howarth , A Williams, AB Tolstrup - Proceedings of the , 2004 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0306294101 Proteasomes and antigen presentation: evidence that a KEKE motif does not promote presentation of the class I epitope SIINFEKL M Gonciarz-Swiatek, M Rechsteiner - Molecular immunology, 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589005004104 Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis M Durantez, C Fayolle, N Casares, V Belsue - Vaccine, 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X10012405 Sortase-mediated modification of alphaDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes LK Swee, CP Guimaraes, S Sehrawat - Proceedings of the , 2013 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1214994110 In vivo generation of cytotoxic T cells from epitopes displayed on peptide-based delivery vehicles KS Kawamura, RC Su , LT Nguyen - The Journal of , 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/168/11/5709/34240 Both human and mouse cells expressing H-2Kb and ovalbumin process the same peptide, SIINFEKL K Falk, O Rötzschke , S Faath, S Goth, I Graef - Cellular , 1993 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874983712128 MHC/peptide binding studies indicate hierarchy of anchor residues K Deres, W Beck, S Faath, G Jung, HG Rammensee - Cellular immunology, 1993 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874983712281 A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the Class I pathway GA Pietersz, W Li, V Apostolopoulos - Vaccine, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X0000373X Poly (propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines F Qiu , KW Becker , FC Knight, JJ Baljon , S Sevimli - Biomaterials, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S014296121830543X Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules E Schott, N Bertho , Q Ge - Proceedings of the , 2002 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.212515399 Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway DS Pouniotis, V Apostolopoulos , GA Pietersz - Immunology, 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2005.02304.x Comparison of protein and peptide targeting for the development of a CD169-based vaccination strategy against melanoma D Van Dinther , H Veninga, M Revet - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2018.01997/full Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer D Nobuoka, T Yoshikawa, M Takahashi - Cancer Immunology , 2013 - Springerhttps://link.springer.com/article/10.1007/s00262-012-1366-6 A SIINFEKL-based system to measure MHC class I antigen presentation efficiency and kinetics D Dersh , JW Yewdell , J Wei - Antigen Processing: Methods and Protocols, 2019 - Springerhttps://link.springer.com/protocol/10.1007/978-1-4939-9450-2_9 Sustained release of granulocyte-macrophage colony-stimulating factor from a modular peptide-based cancer vaccine alters vaccine microenvironment and CL Nguyen, JT Bui, M Demcheva - Journal of , 2001 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2001/09000/Sustained_Release_of_Granulocyte_Macrophage.4.aspx Role of linker length and antigen density in nanoparticle peptide vaccine CH Kapadia , S Tian, JL Perry , JC Luft - ACS omega, 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsomega.8b03391 T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivo AI Webb , MA Dunstone , NA Williamson - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/175/6/3810/73297 Functional screening of a retroviral peptide library for MHC class I presentation AB Tolstrup, M Duch, I Dalum, FS Pedersen - Gene, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378111900005722 Peptide-loaded dendritic cells prime and activate MHC-class I-restricted T cells more efficiently than protein-loaded cross-presenting DC aca– Met, S Buus , MH Claesson - Cellular immunology, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S000887490300128X pDNA-lipoplexes engrafted with flagellin-related peptide induce potent immunity and anti-tumour effects A Faham, T Herringson, C Parish, A Suhrbier - Vaccine, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X11010772 Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide A Craiu, T Akopian, A Goldberg - Proceedings of the , 1997 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.94.20.10850 Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis A Carambia, C Gottwick, D Schwinge, S Stein - , 2021 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/imm.13298 New synthetic non-peptide ligands for classical major histocompatibility complex class I molecules A Bianco , C Brock, C Zabel, T Walk, P Walden - Journal of Biological , 1998 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)59453-4/abstract

• Marchio: Biosynth